Calvin W. Roberts M.d.
Chief Medical Officer of Ophthalmology & Eye Healt
Pharmaceutical Science
Valeant Pharmaceuticals International, Inc.
United States of America
Biography
Dr. Calvin W. Roberts, also known as Cal, M.D., has been the Chief Medical Officer of Ophthalmology & Eye Health at Valeant Pharmaceuticals International, Inc. since August 2013. Dr. Roberts has been Chief Medical Officer and Executive Vice President at Bausch & Lomb Holdings Incorporated since March 2011. He serves as the Chief Medical Officer and Executive Vice President at Bausch & Lomb Holdings Incorporated. Dr. Roberts has been the Chief Medical Officer of Bausch & Lomb Incorporated since March 2011 and also serves as its Executive Vice President. He serves as a Member of the Executive Leadership Team at Bausch & Lomb and coordinate its global D&R efforts across the Vision Care, Pharmaceuticals and Surgical business units for greater leverage and outcomes. He has been a Clinical Professor of ophthalmology at Weill Medical College of Cornell University since 1982. He has been a Consultant to ophthalmic pharmaceutical companies, including Allergan Pharmaceuticals, Johnson & Johnson and Novartis since 1989. He served as Corporate Vice President at Bausch & Lomb Incorporated since March 2011. He has been an Independent Director at Alimera Sciences, Inc. since 2003. He has been a Director at Alimera Sciences Limited since 2003. He has been a Director of Auris Medical Holding AG since 2015. He served as Founding Director of Alimera Sciences, Inc. He holds patents on the wide-field specular microscope, used for corneal endothelial studies and is the developer of instruments for cataract surgery. He specializes in cataract and refractive surgery in his New York City private practice. He is credited with developing and producing over-the-counter products for vision care, prescription ocular therapeutics and innovative treatment regimens. He is considered to be the "father" of ophthalmic non-steroidals; he has published 50 peer-reviewed articles. He completed cornea fellowships at Massachusetts Eye and Ear Infirmary and the Schepens Eye Research Institute in Boston. He holds an A.B. from Princeton University and an M.D. from the College of Physicians and Surgeons of Columbia University and he completed his internship and ophthalmology residency at Columbia Presbyterian Hospital in New York.
Research Interest
Pharmaceutical Science